118 related articles for article (PubMed ID: 1663227)
1. Behavioural evidence that systemic morphine may modulate a phasic pain-related behaviour in a rat model of peripheral mononeuropathy.
Attal N; Chen YL; Kayser V; Guilbaud G
Pain; 1991 Oct; 47(1):65-70. PubMed ID: 1663227
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy.
Kayser V; Lee SH; Guilbaud G
Neuroscience; 1995 Jan; 64(2):537-45. PubMed ID: 7700537
[TBL] [Abstract][Full Text] [Related]
3. The bidirectional dose-dependent effect of systemic naloxone is also related to the intensity and duration of pain-related disorders: a study in a rat model of peripheral mononeuropathy.
Attal N; Kayser V; Guilbaud G
Brain Res; 1990 Aug; 525(1):170-4. PubMed ID: 2173962
[TBL] [Abstract][Full Text] [Related]
4. The 'tonic' pain-related behaviour seen in mononeuropathic rats is modulated by morphine and naloxone.
Jazat F; Guilbaud G
Pain; 1991 Jan; 44(1):97-102. PubMed ID: 2038495
[TBL] [Abstract][Full Text] [Related]
5. Behavioural evidence for a bidirectional effect of systemic naloxone in a model of experimental neuropathy in the rat.
Attal N; Kayser V; Jazat F; Guilbaud G
Brain Res; 1989 Aug; 494(2):276-84. PubMed ID: 2776018
[TBL] [Abstract][Full Text] [Related]
6. Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy.
Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
J Pharmacol Exp Ther; 1997 Sep; 282(3):1366-72. PubMed ID: 9316848
[TBL] [Abstract][Full Text] [Related]
7. A time course analysis of the changes in spontaneous and evoked behaviour in a rat model of neuropathic pain.
Kupers RC; Nuytten D; De Castro-Costa M; Gybels JM
Pain; 1992 Jul; 50(1):101-111. PubMed ID: 1325048
[TBL] [Abstract][Full Text] [Related]
8. Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors.
Catheline G; Kayser V; Guilbaud G
Eur J Pharmacol; 1996 Nov; 315(2):135-43. PubMed ID: 8960876
[TBL] [Abstract][Full Text] [Related]
9. The antinociceptive effect of tramadol on a model of neuropathic pain in rats.
Apaydin S; Uyar M; Karabay NU; Erhan E; Yegul I; Tuglular I
Life Sci; 2000 Mar; 66(17):1627-37. PubMed ID: 11261592
[TBL] [Abstract][Full Text] [Related]
10. Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic rats.
Lee SH; Kayser V; Desmeules J; Guilbaud G
Pain; 1994 May; 57(2):233-240. PubMed ID: 8090518
[TBL] [Abstract][Full Text] [Related]
11. Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy.
Attal N; Jazat F; Kayser V; Guilbaud G
Pain; 1990 May; 41(2):235-251. PubMed ID: 2164179
[TBL] [Abstract][Full Text] [Related]
12. Differential behavioral effects of peripheral and systemic morphine and naloxone in a rat model of repeated acute inflammation.
Perrot S; Guilbaud G; Kayser V
Anesthesiology; 2001 May; 94(5):870-5. PubMed ID: 11388540
[TBL] [Abstract][Full Text] [Related]
13. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy.
Yamamoto T; Yaksh TL
Neurosci Lett; 1992 Jan; 135(1):67-70. PubMed ID: 1311824
[TBL] [Abstract][Full Text] [Related]
14. Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain.
Desmeules JA; Kayser V; Guilbaud G
Pain; 1993 Jun; 53(3):277-285. PubMed ID: 8394563
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of various doses of morphine and naloxone on two nociceptive test thresholds in arthritic and normal rats.
Kayser V; Guilbaud G
Pain; 1990 Jun; 41(3):353-363. PubMed ID: 2388772
[TBL] [Abstract][Full Text] [Related]
16. In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics.
Idänpään-Heikkilä JJ; Perrot S; Guilbaud G; Kayser V
Eur J Pharmacol; 1997 May; 325(2-3):155-64. PubMed ID: 9163562
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive effects of acute and 'chronic' injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats.
Ardid D; Guilbaud G
Pain; 1992 May; 49(2):279-287. PubMed ID: 1608650
[TBL] [Abstract][Full Text] [Related]
18. The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats.
Martinez V; Christensen D; Kayser V
Pain; 2002 Oct; 99(3):537-545. PubMed ID: 12406530
[TBL] [Abstract][Full Text] [Related]
19. Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Anesthesiology; 2000 Mar; 92(3):786-94. PubMed ID: 10719957
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of intrathecally administered morphine and its interaction with cholecystokinin-B antagonist on thermal hyperalgesia following two models of experimental mononeuropathy in the rat.
Yamamoto T; Sakashita Y
Anesthesiology; 1999 May; 90(5):1382-91. PubMed ID: 10319787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
